Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Instagram Outage Disrupts Thousands of U.S. Users 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Las Vegas, NV, March 01, 2018 -- StereoVision Entertainment Inc (OTC:SVSN) a publicly traded Nevada company announced today that Trammell Crow has joined the Advisory Board of their majority owned subsidiary CannaVision, with immediate effect.
“We’ve been preparing for our entry into the industrial hemp industry for some time,” said CannaVision’s Chairman and Chief Medical Officer Dr. Jay Ellenby M.D., F.A.S.C. “Our Board members, CannaVision President Marla Mahloch, retired criminal court judge and practicing Puerto Rico attorney Walter Marrero, multi-generational Iowa farmer Dave Hegland, Fortune 500 marketer Theresa Galdony, our Chief Operating Officer Wall Street veteran Steven Previch, our General Counsel Christopher Dieterich, our physicians, Dr. F. Scott Sherman M.D., Dr. Charles Picket D.O., and Dr. M. Sheldon Polsky M.D., our Master Agronomist Marc Ellenby who says “every day on his farm is Earth Day”, and our staff, are extremely proud to welcome Mr. Crow to our Advisory Board. His international recognition and influence as a dedicated environmentalist will be invaluable as we roll out our plan for entering the global organic hemp industry.”
Trammell Crow added, “I look forward to working with the CannaVision team as we explore the many possibilities for commercializing this eco-friendly renewable resource.”
StereoVision Entertainment http://stereovision.com Headquartered in Las Vegas, Nevada StereoVision is a publicly traded Nevada corporation (OTC:SVSN) focused on creating, acquiring, and producing multimedia content with its media subsidiaries, the wholly owned 9 time Emmy Award winning production company REZN8, http://rezn8.com, the majority owned family entertainment company, Inspirational Vision Media, http://ivmi.biz, and the majority owned Florida medical marijuana clinic and organic hemp corporation MediCannaVision Inc., dba CannaVision. http://cannavisionclinics.com
Safe Harbor Statement:
Except for historical information certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are qualified by other factors. The Company undertakes no obligation to publicly update any statements in this release, whether as a result of future events, or otherwise.
Contact: Steven Previch 305-972-2018 [email protected]
